Cue Biopharma, Inc. (CUE)
31.40
-3.60
(-10.29%)
USD |
NASDAQ |
May 11, 16:00
31.40
0.00 (0.00%)
After-Hours: 18:06
Cue Biopharma EPS Diluted (Quarterly) : 0.4302 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Moderna, Inc. | -3.40 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
| Savara, Inc. | -0.1341 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.585M |
| Revenue (Quarterly) | 21.94M |
| Total Expenses (Quarterly) | 20.36M |
| Enterprise Value | 91.00M |
| Gross Profit Margin (Quarterly) | 99.69% |
| Profit Margin (Quarterly) | 7.22% |
| Earnings Yield | -14.70% |
| Normalized Earnings Yield | -14.70 |